Glucagon-Like Peptide-1 Agonists to Manage Weight Gain in Patients Taking Antipsychotics [poster]
Patients struggling with schizophrenia have significant weight gain and lower life expectancy than the general population. These differences may be the result of commonly prescribed antipsychotic medications.
Nash, Samuel
core
Tardive Oropharyngeal Dyskinesia Associated With Antipsychotic Use in the Management of Behavioral and Psychological Symptoms of Dementia. [PDF]
J Med CasesZohari Z +4 more
europepmc +1 more source
Trends in antipsychotic and lithium use in Scandinavian countries from 2010 to 2023: a cross-country drug utilization study. [PDF]
BMC PsychiatryHakimi NH, Larsen MD, Bojanic I.
europepmc +1 more source
A meta-analysis of the incidence proportion of obesity and associated risk factors in patients with schizophrenia. [PDF]
Front PsychiatryLong J, Yang B, Zheng Q.
europepmc +1 more source
Revisiting the Management of Treatment-Resistant Depression. [PDF]
Can J PsychiatryLee JJ, Blumberger DM.
europepmc +1 more source
High Adherence to Pharmacological Treatment Guidelines in Recovery and Remission States Among Patients With Schizophrenia: A Cross-Sectional Study. [PDF]
Neuropsychopharmacol RepAsada R +4 more
europepmc +1 more source
Long-Acting Injectable Antipsychotics and Time to Readmission in Early Psychosis. [PDF]
J Child Adolesc PsychopharmacolWang C +10 more
europepmc +1 more source
Antipsychotic dose and efficacy for acute schizophrenia spectrum disorders: an updated systematic review and dose-response meta-analysis. [PDF]
EClinicalMedicineFurukawa Y +9 more
europepmc +1 more source
Congenital malformation risk following prenatal antipsychotic exposure: a systematic safety surveillance approach. [PDF]
BMJ Ment HealthStraub L +10 more
europepmc +1 more source